{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T06:44:20Z","timestamp":1793774660729,"version":"4.6.1"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T00:00:00Z","timestamp":1584489600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T00:00:00Z","timestamp":1584489600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s11910-020-01030-w","type":"journal-article","created":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T13:28:14Z","timestamp":1584538094000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Emergency Department and Inpatient Management of Headache in Adults"],"prefix":"10.1007","volume":"20","author":[{"given":"Jennifer","family":"Robblee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate W.","family":"Grimsrud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,18]]},"reference":[{"issue":"1","key":"1030_CR1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.5144\/0256-4947.2016.51","volume":"36","author":"E Coban","year":"2016","unstructured":"Coban E, Mutluay B, Sen A, Keskek A, Atakl D, Soysal A. Characteristics, diagnosis and outcome of patients referred to a specialized neurology emergency clinic: prospective observational study. Annals of Saudi medicine. 2016;36(1):51\u20136.","journal-title":"Annals of Saudi medicine"},{"issue":"3","key":"1030_CR2","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1468-1331.2010.03170.x","volume":"18","author":"T Rizos","year":"2011","unstructured":"Rizos T, J\u00fcttler E, Sykora M, Poli S, Ringleb PA. Common disorders in the neurological emergency room--experience at a tertiary care hospital. Eur J Neurol. 2011;18(3):430\u20135.","journal-title":"Eur J Neurol"},{"issue":"1","key":"1030_CR3","doi-asserted-by":"crossref","first-page":"e0208728","DOI":"10.1371\/journal.pone.0208728","volume":"14","author":"J Munoz-Ceron","year":"2019","unstructured":"\u2022 Munoz-Ceron J, Marin-Careaga V, Pena L, Mutis J, Ortiz G. Headache at the emergency room: Etiologies, diagnostic usefulness of the ICHD 3 criteria, red and green flags. PLoS One. 2019;14(1):e0208728 Useful observational study on diagnosis of headache presentations in the emergency room.","journal-title":"PLoS One"},{"key":"1030_CR4","doi-asserted-by":"crossref","unstructured":"Vo P, Gao W, Zichlin ML, Fuqua E, Fadli E, Aguirre Vazquez M, et al. Migraine-related healthcare resource use in the emergency department setting: a panel-based chart review in France, Germany, Italy, and Spain. J Med Econ. 2019;22(9):960\u20136.","DOI":"10.1080\/13696998.2019.1636052"},{"issue":"10","key":"1030_CR5","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1111\/head.13421","volume":"58","author":"SD Silberstein","year":"2018","unstructured":"Silberstein SD, Lee L, Gandhi K, Fitzgerald T, Bell J, Cohen JM. Health care resource utilization and migraine disability along the migraine continuum among patients treated for migraine. Headache. 2018;58(10):1579\u201392.","journal-title":"Headache."},{"key":"1030_CR6","doi-asserted-by":"crossref","unstructured":"Bonafede M, Cai Q, Cappell K, Kim G, Sapra SJ, Shah N, et al. Factors associated with direct health care costs among patients with migraine. J Manag Care Spec Pharm. 2017;23(11):1169\u201376.","DOI":"10.18553\/jmcp.2017.23.11.1169"},{"issue":"9","key":"1030_CR7","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1111\/head.13387","volume":"58","author":"MT Minen","year":"2018","unstructured":"\u2022 Minen MT, Ortega E, Lipton RB, Cowan R. American Headache Society survey about urgent and emergency management of headache patients. Headache. 2018;58(9):1389\u201396 This study looked at satisfaction of emergency management among headache providers.","journal-title":"Headache."},{"issue":"2","key":"1030_CR8","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1177\/0333102416686341","volume":"38","author":"TD Singh","year":"2018","unstructured":"Singh TD, Cutrer FM, Smith JH. Episodic status migrainosus: a novel migraine subtype. Cephalalgia. 2018;38(2):304\u201311.","journal-title":"Cephalalgia."},{"key":"1030_CR9","doi-asserted-by":"crossref","unstructured":"Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1\u2013211","DOI":"10.1177\/0333102417738202"},{"issue":"11","key":"1030_CR10","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/j.1468-2982.2009.01842.x","volume":"29","author":"RB Grande","year":"2009","unstructured":"Grande RB, Aaseth K, Lundqvist C, Russell MB. Prevalence of new daily persistent headache in the general population. The Akershus study of chronic headache. Cephalalgia. 2009;29(11):1149\u201355.","journal-title":"Cephalalgia."},{"issue":"8","key":"1030_CR11","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1177\/0333102414520763","volume":"34","author":"M Beltramone","year":"2014","unstructured":"\u2022 Beltramone M, Donnet A. Status migrainosus and migraine aura status in a French tertiary-care center: an 11-year retrospective analysis. Cephalalgia. 2014;34(8):633\u20137 This study is one of few epidemiologic studies for status migrainosus.","journal-title":"Cephalalgia."},{"issue":"8","key":"1030_CR12","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1177\/0883073810397631","volume":"26","author":"G Legault","year":"2011","unstructured":"Legault G, Eisman H, Shevell MI. Treatment of pediatric status migrainosus: can we prevent the \"bounce back\"? J Child Neurol. 2011;26(8):949\u201355.","journal-title":"J Child Neurol"},{"issue":"9","key":"1030_CR13","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3390\/jcm7090269","volume":"7","author":"T Harnod","year":"2018","unstructured":"Harnod T, Lin C-L, Kao C-H. Risk and predisposing factors for suicide attempts in patients with migraine and status migrainosus: a nationwide population-based study. J Clin Med. 2018;7(9):269.","journal-title":"J Clin Med"},{"issue":"4","key":"1030_CR14","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1177\/1941874416641467","volume":"6","author":"SY Modi","year":"2016","unstructured":"Modi SY, Dharaiya D, Katramados AM, Mitsias P. Predictors of prolonged hospital stay in status migrainosus. Neurohospitalist. 2016;6(4):141\u20136.","journal-title":"Neurohospitalist."},{"issue":"9","key":"1030_CR15","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1111\/head.12648","volume":"55","author":"BL Nye","year":"2015","unstructured":"\u2022 Nye BL, Ward TN. Clinic and emergency room evaluation and testing of headache. Headache. 2015;55(9):1301\u20138 A great review article from 2015 on emergency department management of headache.","journal-title":"Headache."},{"issue":"1","key":"1030_CR16","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1055\/s-0029-1245000","volume":"30","author":"DW Dodick","year":"2010","unstructured":"Dodick DW. Pearls: headache. Semin Neurol. 2010;30(1):74\u201381.","journal-title":"Semin Neurol"},{"key":"1030_CR17","doi-asserted-by":"crossref","unstructured":"Loder E, Weizenbaum E, Frishberg B, Silberstein S, American Headache Society Choosing Wisely Task Force. Choosing wisely in headache medicine: the American Headache Society's list of five things physicians and patients should question. Headache. 2013;53(10):1651\u20139.","DOI":"10.1111\/head.12233"},{"issue":"3","key":"1030_CR18","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.09.067","volume":"27","author":"NI Khan","year":"2018","unstructured":"Khan NI, Chaku S, Goehl C, Endris L, Mueller-Luckey G, Siddiqui FM. Novel algorithm to help identify stroke mimics. J Stroke Cerebrovasc Dis. 2018;27(3):703\u20138.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"8","key":"1030_CR19","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1177\/0333102417736901","volume":"38","author":"ER Lebedeva","year":"2018","unstructured":"Lebedeva ER, Gurary NM, Gilev DV, Christensen AF, Olesen J. Explicit diagnostic criteria for transient ischemic attacks to differentiate it from migraine with aura. Cephalalgia. 2018;38(8):1463\u201370.","journal-title":"Cephalalgia."},{"issue":"Suppl 2","key":"1030_CR20","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1526-4610.1990.hed30s2550.x","volume":"30","author":"NH Raskin","year":"1990","unstructured":"Raskin NH. Treatment of status migrainosus: the American experience. Headache. 1990;30(Suppl 2):550\u20133.","journal-title":"Headache."},{"issue":"9","key":"1030_CR21","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1111\/head.12443","volume":"54","author":"L Richer","year":"2014","unstructured":"Richer L, Craig W, Rowe B. Randomized controlled trial of treatment expectation and intravenous fluid in pediatric migraine. Headache. 2014;54(9):1496\u2013505.","journal-title":"Headache."},{"issue":"2","key":"1030_CR22","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.annemergmed.2018.09.004","volume":"73","author":"CW Jones","year":"2019","unstructured":"Jones CW, Remboski LB, Freeze B, Braz VA, Gaughan JP, McLean SA. Intravenous fluid for the treatment of emergency department patients with migraine headache: a randomized controlled trial. Ann Emerg Med. 2019;73(2):150\u20136.","journal-title":"Ann Emerg Med"},{"issue":"4","key":"1030_CR23","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ajem.2015.12.080","volume":"34","author":"JEB Balbin","year":"2016","unstructured":"Balbin JEB, Nerenberg R, Baratloo A, Friedman BW. Intravenous fluids for migraine: a post hoc analysis of clinical trial data. Am J Emerg Med. 2016;34(4):713\u20136.","journal-title":"Am J Emerg Med"},{"issue":"5","key":"1030_CR24","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/PEC.0b013e31816ed047","volume":"24","author":"B Bailey","year":"2008","unstructured":"Bailey B, McManus BC. Treatment of children with migraine in the emergency department: a qualitative systematic review. Pediatr Emerg Care. 2008;24(5):321\u201330.","journal-title":"Pediatr Emerg Care"},{"issue":"20","key":"1030_CR25","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1212\/WNL.0000000000004642","volume":"89","author":"BW Friedman","year":"2017","unstructured":"\u2022\u2022 Friedman BW, Irizarry E, Solorzano C, et al. Randomized study of IV prochlorperazine plus diphenhydramine vs IV hydromorphone for migraine. Neurology. 2017;89(20):2075\u201382 One of a handful of RCTs available for emergency room \/ status migrainosus treatment with important finding of prochlorperazine outperforming hydromorphone.","journal-title":"Neurology."},{"key":"1030_CR26","doi-asserted-by":"crossref","unstructured":"Friedman BW, Garber L, Yoon A, Solorzano C, Wollowitz A, Esses D, et al. Randomized trial of IV valproate vs metoclopramide vs ketorolac for acute migraine. Neurology. 2014;82(11):976\u201383.","DOI":"10.1212\/WNL.0000000000000223"},{"issue":"2","key":"1030_CR27","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0196-0644(05)80201-X","volume":"22","author":"GL Ellis","year":"1993","unstructured":"Ellis GL, Delaney J, DeHart DA, Owens A. The efficacy of metoclopramide in the treatment of migraine headache. Ann Emerg Med. 1993;22(2):191\u20135.","journal-title":"Ann Emerg Med"},{"key":"1030_CR28","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.clineuro.2014.01.002","volume":"119","author":"U Utku","year":"2014","unstructured":"Utku U, Gokce M, Benli EM, Dinc A, Tuncel D. Intra-venous chlorpromazine with fluid treatment in status migrainosus. Clin Neurol Neurosurg. 2014;119:4\u20135.","journal-title":"Clin Neurol Neurosurg"},{"issue":"1","key":"1030_CR29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11940-011-0150-9","volume":"14","author":"MJ Marmura","year":"2012","unstructured":"Marmura MJ. Use of dopamine antagonists in treatment of migraine. Curr Treat Options Neurol. 2012;14(1):27\u201335.","journal-title":"Curr Treat Options Neurol"},{"key":"1030_CR30","doi-asserted-by":"crossref","unstructured":"D'Souza RS, Mercogliano C, Ojukwu E, D'Souza S, Singles A, Modi J, et al. Effects of prophylactic anticholinergic medications to decrease extrapyramidal side effects in patients taking acute antiemetic drugs: a systematic review and meta-analysis. Emerg Med J : EMJ. 2018;35(5):325\u201331.","DOI":"10.1136\/emermed-2017-206944"},{"issue":"7","key":"1030_CR31","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/PEC.0000000000000525","volume":"32","author":"CR Kaar","year":"2016","unstructured":"Kaar CR, Gerard JM, Nakanishi AK. The use of a pediatric migraine practice guideline in an emergency department setting. Pediatr Emerg Care. 2016;32(7):435\u20139.","journal-title":"Pediatr Emerg Care"},{"issue":"10","key":"1030_CR32","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1111\/head.12694","volume":"55","author":"M Kabbouche","year":"2015","unstructured":"Kabbouche M. Management of pediatric migraine headache in the emergency room and infusion center. Headache. 2015;55(10):1365\u201370.","journal-title":"Headache."},{"issue":"2","key":"1030_CR33","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jemermed.2013.08.049","volume":"46","author":"E Gertsch","year":"2014","unstructured":"Gertsch E, Loharuka S, Wolter-Warmerdam K, Tong S, Kempe A, Kedia S. Intravenous magnesium as acute treatment for headaches: a pediatric case series. J Emerg Med. 2014;46(2):308\u201312.","journal-title":"J Emerg Med"},{"key":"1030_CR34","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.pediatrneurol.2016.09.009","volume":"66","author":"GR Nelson","year":"2017","unstructured":"Nelson GR, Bale JF, Kerr LM. Outcome and cost of inpatient hospitalization for intravenous dihydroergotamine treatment of refractory pediatric headache. Pediatr Neurol. 2017;66:76\u201381.","journal-title":"Pediatr Neurol"},{"issue":"2","key":"1030_CR35","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/NRL.0000000000000161","volume":"23","author":"MS Zafar","year":"2018","unstructured":"Zafar MS, Stewart AM, Toupin DN, Cook AM, Baumann RJ. Continuous intravenous valproate as abortive therapy for pediatric status migrainosus. Neurologist. 2018;23(2):43\u20136.","journal-title":"Neurologist"},{"issue":"2","key":"1030_CR36","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0196-0644(03)00716-9","volume":"43","author":"DC Brousseau","year":"2004","unstructured":"Brousseau DC, Duffy SJ, Anderson AC, Linakis JG. Treatment of pediatric migraine headaches: a randomized, double-blind trial of prochlorperazine versus ketorolac. Ann Emerg Med. 2004;43(2):256\u201362.","journal-title":"Ann Emerg Med"},{"key":"1030_CR37","doi-asserted-by":"crossref","unstructured":"Evers S, Afra J, Frese A, Goadsby PJ, Linde M, May A, et al. EFNS guideline on the drug treatment of migraine--revised report of an EFNS task force. Eur J Neurol. 2009;16(9):968\u201381.","DOI":"10.1111\/j.1468-1331.2009.02748.x"},{"issue":"1","key":"1030_CR38","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/head.12499","volume":"55","author":"MJ Marmura","year":"2015","unstructured":"\u2022\u2022 Marmura MJ, Silberstein SD, Schwedt TJ. The acute treatment of migraine in adults: the American Headache Society evidence assessment of migraine pharmacotherapies. Headache. 2015;55(1):3\u201320 AHS evidence recommendations for acute migraine treatment including some options offered for emergency room management.","journal-title":"Headache."},{"issue":"3","key":"1030_CR39","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1046\/j.1526-4610.1997.3703129.x","volume":"37","author":"RG Ford","year":"1997","unstructured":"Ford RG, Ford KT. Continuous intravenous dihydroergotamine in the treatment of intractable headache. Headache. 1997;37(3):129\u201336.","journal-title":"Headache."},{"key":"1030_CR40","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3389\/fneur.2019.00201","volume":"10","author":"N Haque","year":"2019","unstructured":"Haque N, Tariq N. Short term oral methylergonovine maleate prophylaxis for status migrainosus Case Series and Review of Literature. Front Neurol. 2019;10:201.","journal-title":"Front Neurol"},{"issue":"11","key":"1030_CR41","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1177\/0333102414566200","volume":"35","author":"YW Woldeamanuel","year":"2015","unstructured":"\u2022 Woldeamanuel YW, Rapoport AM, Cowan RP. The place of corticosteroids in migraine attack management: A 65-year systematic review with pooled analysis and critical appraisal. Cephalalgia. 2015;35(11):996\u20131024 Systematic review on the use of steroids for acute migraine treatment.","journal-title":"Cephalalgia."},{"issue":"6","key":"1030_CR42","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1526-4610.1994.hed3406366.x","volume":"34","author":"HA Saadah","year":"1994","unstructured":"Saadah HA. Abortive migraine therapy in the office with dexamethasone and prochlorperazine. Headache. 1994;34(6):366\u201370.","journal-title":"Headache."},{"key":"1030_CR43","doi-asserted-by":"crossref","unstructured":"Gungor F, Akyol KC, Kesapli M, Celik A, Karaca A, Bozdemir MN, et al. Intravenous dexketoprofen vs placebo for migraine attack in the emergency department: a randomized, placebo-controlled trial. Cephalalgia. 2016;36(2):179\u201384.","DOI":"10.1177\/0333102415584604"},{"issue":"2","key":"1030_CR44","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1159\/000008009","volume":"41","author":"V Limmroth","year":"1999","unstructured":"Limmroth V, May A, Diener H. Lysine-acetylsalicylic acid in acute migraine attacks. Eur Neurol. 1999;41(2):88\u201393.","journal-title":"Eur Neurol"},{"issue":"46","key":"1030_CR45","doi-asserted-by":"crossref","first-page":"e17734","DOI":"10.1097\/MD.0000000000017734","volume":"98","author":"B Yang","year":"2019","unstructured":"Yang B, Xu Z, Chen L, Chen X, Xie Y. The efficacy of dexketoprofen for migraine attack: a meta-analysis of randomized controlled studies. Medicine. 2019;98(46):e17734.","journal-title":"Medicine"},{"issue":"2","key":"1030_CR46","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/head.12009","volume":"53","author":"E Taggart","year":"2013","unstructured":"Taggart E, Doran S, Kokotillo A, Campbell S, Villa-Roel C, Rowe BH. Ketorolac in the treatment of acute migraine: a systematic review. Headache. 2013;53(2):277\u201387.","journal-title":"Headache."},{"issue":"10","key":"1030_CR47","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1111\/head.13648","volume":"59","author":"AC Miller","year":"2019","unstructured":"Miller AC, K Pfeffer B, Lawson MR, Sewell KA, King AR, Zehtabchi S. Intravenous magnesium sulfate to treat acute headaches in the emergency department: a systematic review. Headache. 2019;59(10):1674\u201386.","journal-title":"Headache."},{"key":"1030_CR48","doi-asserted-by":"crossref","unstructured":"Xu F, Arakelyan A, Spitzberg A, Green L, Cesar PH, Csere A, et al. Experiences of an outpatient infusion center with intravenous magnesium therapy for status migrainosus. Clin Neurol Neurosurg. 2019;178:31\u20135.","DOI":"10.1016\/j.clineuro.2019.01.007"},{"issue":"9","key":"1030_CR49","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1080\/01616412.2016.1206164","volume":"38","author":"ET Van Matre","year":"2016","unstructured":"Van Matre ET, Cook AM. Steady-state pharmacokinetic simulation of intermittent vs. continuous infusion valproic acid therapy in non-critically ill and critically ill patients. Neurol Res. 2016;38(9):786\u201391.","journal-title":"Neurol Res"},{"issue":"10","key":"1030_CR50","first-page":"633","volume":"53","author":"F Ghaderibarmi","year":"2015","unstructured":"Ghaderibarmi F, Tavakkoli N, Togha M. Intravenous valproate versus subcutaneous sumatriptan in acute migraine attack. Acta medica Iranica. 2015;53(10):633\u20136.","journal-title":"Acta medica Iranica"},{"key":"1030_CR51","doi-asserted-by":"crossref","unstructured":"Leinisch E, Evers S, Kaempfe N, Kraemer C, Sostak P, J\u00fcrgens T, et al. Evaluation of the efficacy of intravenous acetaminophen in the treatment of acute migraine attacks: a double-blind, placebo-controlled parallel group multicenter study. Pain. 2005;117(3):396\u2013400.","DOI":"10.1016\/j.pain.2005.07.002"},{"key":"1030_CR52","doi-asserted-by":"crossref","unstructured":"Bennett MH, French C, Schnabel A, Wasiak J, Kranke P, Weibel S. Normobaric and hyperbaric oxygen therapy for the treatment and prevention of migraine and cluster headache. Cochrane Database Syst Rev. 2015; (12):CD005219-CD.","DOI":"10.1002\/14651858.CD005219.pub3"},{"issue":"9","key":"1030_CR53","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1111\/head.13395","volume":"58","author":"BW Friedman","year":"2018","unstructured":"\u2022 Friedman BW, Mohamed S, Robbins MS, et al. A randomized, sham-controlled trial of bilateral greater occipital nerve blocks with bupivacaine for acute migraine patients refractory to standard emergency department treatment with metoclopramide. Headache. 2018;58(9):1427\u201334 One of a handful of recent randomized clinical trials available for emergency room \/ status migrainosus treatment.","journal-title":"Headache"},{"issue":"3","key":"1030_CR54","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/ane.12952","volume":"138","author":"O Korucu","year":"2018","unstructured":"Korucu O, Dagar S, \u00c7orbacioglu \u015eK, Emektar E, Cevik Y. The effectiveness of greater occipital nerve blockade in treating acute migraine-related headaches in emergency departments. Acta Neurol Scand. 2018;138(3):212\u20138.","journal-title":"Acta Neurol Scand"},{"key":"1030_CR55","doi-asserted-by":"crossref","unstructured":"\u2022 Rozen TD. Emergency department and inpatient management of status migrainosus and intractable headache. Continuum (Minneap Minn). 2015;21(4 Headache):1004\u201317 A great review article from 2015 on emergency department management of headache.","DOI":"10.1212\/CON.0000000000000191"},{"issue":"3","key":"1030_CR56","doi-asserted-by":"crossref","first-page":"e0120229","DOI":"10.1371\/journal.pone.0120229","volume":"10","author":"S Mazaheri","year":"2015","unstructured":"Mazaheri S, Poorolajal J, Hosseinzadeh A, Fazlian MM. Effect of intravenous sodium valproate vs dexamethasone on acute migraine headache: a double blind randomized clinical trial. PLoS One. 2015;10(3):e0120229.","journal-title":"PLoS One"},{"issue":"1","key":"1030_CR57","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1212\/WNL.48.1.261","volume":"48","author":"JF Rothrock","year":"1997","unstructured":"Rothrock JF. Successful treatment of persistent migraine aura with divalproex sodium. Neurology. 1997;48(1):261\u20132.","journal-title":"Neurology."},{"issue":"10","key":"1030_CR58","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1212\/WNL.55.10.1588","volume":"55","author":"J Haan","year":"2000","unstructured":"Haan J, Sluis P, Sluis LH, Ferrari MD. Acetazolamide treatment for migraine aura status. Neurology. 2000;55(10):1588\u20139.","journal-title":"Neurology."},{"issue":"4","key":"1030_CR59","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1526-4610.2005.05077_3.x","volume":"45","author":"R De Simone","year":"2005","unstructured":"De Simone R, Marano E, Di Stasio E, Bonuso S, Fiorillo C, Bonavita V. Acetazolamide efficacy and tolerability in migraine with aura: a pilot study. Headache. 2005;45(4):385\u20136.","journal-title":"Headache."},{"key":"1030_CR60","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1752-1947-8-61","volume":"8","author":"J Lim","year":"2014","unstructured":"Lim J, Jo KD, Lee MK, Jang W. Persistent negative visual aura in migraine without headache: a case report. J Med Case Rep. 2014;8:61.","journal-title":"J Med Case Rep"},{"issue":"8","key":"1030_CR61","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/head.13615","volume":"59","author":"D Buch","year":"2019","unstructured":"Buch D, Chabriat H. Lamotrigine in the prevention of migraine with aura: a narrative review. Headache. 2019;59(8):1187\u201397.","journal-title":"Headache."},{"issue":"8","key":"1030_CR62","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1111\/head.12392","volume":"54","author":"S Thissen","year":"2014","unstructured":"Thissen S, Vos IG, Schreuder TH, Schreurs WMJ, Postma LA, Koehler PJ. Persistent migraine aura: new cases, a literature review, and ideas about pathophysiology. Headache. 2014;54(8):1290\u2013309.","journal-title":"Headache."},{"key":"1030_CR63","doi-asserted-by":"crossref","unstructured":"Bogdanov VB, Multon S, Chauvel V, Bogdanova OV, Prodanov D, Makarchuk MY, et al. Migraine preventive drugs differentially affect cortical spreading depression in rat. Neurobiol Dis. 2011;41(2):430\u20135.","DOI":"10.1016\/j.nbd.2010.10.014"},{"key":"1030_CR64","doi-asserted-by":"crossref","unstructured":"D'Andrea G, Nordera GP, Allais G. Treatment of aura: solving the puzzle. Neurol Sci. 2006;27(Suppl 2):S96\u2013S9.","DOI":"10.1007\/s10072-006-0579-x"},{"issue":"6","key":"1030_CR65","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/01.WNF.0000236766.08409.03","volume":"29","author":"F Brighina","year":"2006","unstructured":"Brighina F, Palermo A, Aloisio A, Francolini M, Giglia G, Fierro B. Levetiracetam in the prophylaxis of migraine with aura: a 6-month open-label study. Clin Neuropharmacol. 2006;29(6):338\u201342.","journal-title":"Clin Neuropharmacol"},{"issue":"5","key":"1030_CR66","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1212\/WNL.55.5.732","volume":"55","author":"TD Rozen","year":"2000","unstructured":"Rozen TD. Treatment of a prolonged migrainous aura with intravenous furosemide. Neurology. 2000;55(5):732\u20133.","journal-title":"Neurology."},{"issue":"4","key":"1030_CR67","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1590\/S1807-59322009000400019","volume":"64","author":"RF de Almeida","year":"2009","unstructured":"de Almeida RF, Le\u00e3o IAT, Gomes JBL, da Silva AA Jr, Teixeira AL. Migraine with persistent visual aura: response to furosemide. Clinics (Sao Paulo, Brazil). 2009;64(4):375\u20136.","journal-title":"Clinics (Sao Paulo, Brazil)"},{"issue":"7","key":"1030_CR68","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1212\/WNL.0b013e3182824e66","volume":"80","author":"SK Afridi","year":"2013","unstructured":"Afridi SK, Giffin NJ, Kaube H, Goadsby PJ. A randomized controlled trial of intranasal ketamine in migraine with prolonged aura. Neurology. 2013;80(7):642\u20137.","journal-title":"Neurology."},{"issue":"1","key":"1030_CR69","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s10194-016-0700-3","volume":"17","author":"C Lauritsen","year":"2016","unstructured":"Lauritsen C, Mazuera S, Lipton RB, Ashina S. Intravenous ketamine for subacute treatment of refractory chronic migraine: a case series. J Headache Pain. 2016;17(1):106.","journal-title":"J Headache Pain"},{"issue":"2","key":"1030_CR70","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/head.13013","volume":"57","author":"JL Pomeroy","year":"2017","unstructured":"Pomeroy JL, Marmura MJ, Nahas SJ, Viscusi ER. Ketamine infusions for treatment refractory headache. Headache. 2017;57(2):276\u201382.","journal-title":"Headache."},{"issue":"10","key":"1030_CR71","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1526-4610.1991.hed3110658.x","volume":"31","author":"P Jauslin","year":"1991","unstructured":"Jauslin P, Goadsby PJ, Lance JW. The hospital management of severe migrainous headache. Headache. 1991;31(10):658\u201360.","journal-title":"Headache."},{"issue":"3","key":"1030_CR72","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jemermed.2018.12.007","volume":"56","author":"T Benish","year":"2019","unstructured":"Benish T, Villalobos D, Love S, et al. The THINK (Treatment of Headache with Intranasal Ketamine) Trial: a randomized controlled trial comparing intranasal ketamine with intravenous metoclopramide. J Emerg Med. 2019;56(3):248\u201357.e1.","journal-title":"J Emerg Med"},{"key":"1030_CR73","doi-asserted-by":"crossref","unstructured":"Etchison AR, Bos L, Ray M, McAllister K, Mohammed M, Park B, et al. Low-dose ketamine does not improve migraine in the emergency department: a randomized placebo-controlled trial. West J Emerg Med. 2018;19(6):952\u201360.","DOI":"10.5811\/westjem.2018.8.37875"},{"key":"1030_CR74","doi-asserted-by":"crossref","unstructured":"Sheridan DC, Hansen ML, Lin AL, Fu R, Meckler GD. Low-dose propofol for pediatric migraine: a prospective randomized controlled trial. J Emerg Med. 2018;54(5):600\u20136.","DOI":"10.1016\/j.jemermed.2018.01.003"},{"key":"1030_CR75","doi-asserted-by":"crossref","unstructured":"Moshtaghion H, Heiranizadeh N, Rahimdel A, Esmaeili A, Hashemian H, Hekmatimoghaddam S. The efficacy of propofol vs. subcutaneous sumatriptan for treatment of acute migraine headaches in the emergency department: a double-blinded clinical trial. Pain Prac. 2015;15(8):701\u20135.","DOI":"10.1111\/papr.12230"},{"issue":"8","key":"1030_CR76","first-page":"688","volume":"30","author":"S Robert","year":"2013","unstructured":"Robert S, Ghanayem H. Towards evidence-based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 1: propofol for migraine. Emerg Med J : EMJ. 2013;30(8):688\u20139.","journal-title":"Emerg Med J : EMJ"},{"issue":"3","key":"1030_CR77","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1046\/j.1526-4610.2000.00032.x","volume":"40","author":"JC Krusz","year":"2000","unstructured":"Krusz JC, Scott V, Belanger J. Intravenous propofol: unique effectiveness in treating intractable migraine. Headache. 2000;40(3):224\u201330.","journal-title":"Headache."},{"key":"1030_CR78","doi-asserted-by":"publisher","unstructured":"Piatka C, Beckett RD. Propofol for treatment of acute migraine in the emergency department: a systematic review. Acad Emerg Med. 2019. https:\/\/doi.org\/10.1111\/acem.13870.","DOI":"10.1111\/acem.13870"},{"key":"1030_CR79","doi-asserted-by":"crossref","unstructured":"De Simone R, Ranieri A, Ferra G, Cautiero F. Intravenous mannitol in status migrainosus treatment: a clinical case series. Neurol Sci. 2017;38(Suppl 1):163\u20137.","DOI":"10.1007\/s10072-017-2883-z"},{"key":"1030_CR80","doi-asserted-by":"crossref","unstructured":"Fofi L, Giugni E, Vadal\u00e0 R, Vanacore N, Aurilia C, Egeo G, et al. Cerebral transverse sinus morphology as detected by MR venography in patients with chronic migraine. Headache. 2012;52(8):1254\u201361.","DOI":"10.1111\/j.1526-4610.2012.02154.x"},{"key":"1030_CR81","doi-asserted-by":"crossref","unstructured":"Bono F, Salvino D, Tallarico T, Cristiano D, Condino F, Fera F, et al. Abnormal pressure waves in headache sufferers with bilateral transverse sinus stenosis. Cephalalgia. 2010;30(12):1419\u201325.","DOI":"10.1177\/0333102410370877"},{"issue":"4","key":"1030_CR82","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/1941874416651118","volume":"6","author":"EC Landsness","year":"2016","unstructured":"Landsness EC, Wang LH, Bucelli RC. Ziprasidone as a potential abortive therapy for status Migrainosus. Neurohospitalist. 2016;6(4):151\u20136.","journal-title":"Neurohospitalist."},{"issue":"5","key":"1030_CR83","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.bjan.2013.09.010","volume":"65","author":"A Udelsmann","year":"2015","unstructured":"Udelsmann A, Saccomani P, Dreyer E, da Costa ALC. Treatment of status migrainosus by general anesthesia: a case report. Braz J Anesthesiol (Elsevier). 2015;65(5):407\u201310.","journal-title":"Braz J Anesthesiol (Elsevier)"},{"issue":"8","key":"1030_CR84","first-page":"1199","volume":"84","author":"N Poungvarin","year":"2001","unstructured":"Poungvarin N. The first world report of botulinum A toxin injection for status migrainosus. J Med Assoc Thail = Chotmaihet Thangphaet. 2001;84(8):1199\u2013203.","journal-title":"J Med Assoc Thail = Chotmaihet Thangphaet"},{"key":"1030_CR85","doi-asserted-by":"crossref","unstructured":"Grazzi L, Andrasik F, D'Amico D, Leone M, Usai S, Kass SJ, et al. Behavioral and pharmacologic treatment of transformed migraine with analgesic overuse: outcome at 3 years. Headache. 2002;42(6):483\u201390.","DOI":"10.1046\/j.1526-4610.2002.02123.x"},{"issue":"5","key":"1030_CR86","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1046\/j.1526-4610.2000.00057.x","volume":"40","author":"F Hoodin","year":"2000","unstructured":"Hoodin F, Brines BJ, Lake AE 3rd, Wilson J, Saper JR. Behavioral self-management in an inpatient headache treatment unit: increasing adherence and relationship to changes in affective distress. Headache. 2000;40(5):377\u201383.","journal-title":"Headache."},{"issue":"2","key":"1030_CR87","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1526-4610.1993.hed3302055.x","volume":"33","author":"AE Lake 3rd","year":"1993","unstructured":"Lake AE 3rd, Saper JR, Madden SF, Kreeger C. Comprehensive inpatient treatment for intractable migraine: a prospective long-term outcome study. Headache. 1993;33(2):55\u201362.","journal-title":"Headache."},{"key":"1030_CR88","doi-asserted-by":"publisher","unstructured":"Connelly M, Sekhon S, Stephens D, Boorigie M, Bickel J. Enhancing outpatient dihydroergotamine infusion with interdisciplinary care to treat refractory pediatric migraine: preliminary outcomes from the Comprehensive Aggressive Migraine Protocol (\"CAMP\"). Headache. 2019. https:\/\/doi.org\/10.1111\/head.13685.","DOI":"10.1111\/head.13685"},{"issue":"7","key":"1030_CR89","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s10194-012-0469-y","volume":"13","author":"T-M Wallasch","year":"2012","unstructured":"Wallasch T-M, Kropp P. Multidisciplinary integrated headache care: a prospective 12-month follow-up observational study. J Headache Pain. 2012;13(7):521\u20139.","journal-title":"J Headache Pain"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-020-01030-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11910-020-01030-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-020-01030-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T02:53:43Z","timestamp":1666148023000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11910-020-01030-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,18]]},"references-count":89,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["1030"],"URL":"https:\/\/doi.org\/10.1007\/s11910-020-01030-w","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,18]]},"assertion":[{"value":"18 March 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Jennifer Robblee and Kate W Grimsrud each declare no potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors<b>.<\/b>","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"7"}}